SEC ownership of CalciMedica, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001534133.

Comparable stake leader

ALAFI CAPITAL CO LLC

Disclosed value leader

Sanderling Venture Partners VI Co Investment Fund LP

Comparable rows

40/50

Latest evidence

19 Aug 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
40 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
ALAFI CAPITAL CO LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
19 Aug 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001534133
Issuer location
La Jolla, CA

Ownership snapshot

Top shareholders of CalciMedica, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ALAFI CAPITAL CO LLC
Disclosed value leader
Sanderling Venture Partne...
Comparable rows
40/50
Latest evidence
19 Aug 2026
13D/G 3/4/5 13F Lead comparable stake: 20% 10 rows are not safely comparable across share classes. 13D/G row: ALAFI CAPITAL CO LLC Showing 1-8 of 50 holder rows.

Quick read

ALAFI CAPITAL CO LLC leads the comparable SEC ownership view at 20%.

40 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ALAFI CAPITAL CO LLC's linked filing trail.
Comparable ownership Top 5
ALAFI CAPITAL CO LLC 20%
Bering Partners II GP, L.L.C. 10%
ARMISTICE CAPITAL, LLC 10%
Woodline Partners LP 8.1%
Valence Investments SPV VI, LLC 6.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ALAFI CAPITAL CO LLC
13D/G 3/4/5
Alafi Capital Company LLC · 10%+ Owner
20%
$6,064,885
7,220,101 shares
+$1,660,768 19 Aug 2026
Bering Partners II GP, L.L.C.
13D/G
10%
$2,984,854
3,553,398 shares
+$1,209,503 19 Aug 2026
ARMISTICE CAPITAL, LLC
13D/G
10%
$2,797,316
3,411,361 shares
$0 30 Jun 2026
Woodline Partners LP
13F 13D/G
Company
8.1%
from 13D/G
$2,564,421
2,489,729 shares
30 Jun 2026
Valence Investments SPV VI, LLC
13D/G
Eric W. Roberts
6.4%
$1,218,868
1,965,916 shares
$0 25 Jun 2026
Stonepine Capital Management, LLC
13D/G 13F
Company
6%
$1,805,598
2,149,522 shares
+$1,277,514 19 Aug 2026
CVI Investments, Inc.
13D/G
5.1%
$1,602,763
1,556,081 shares
$0 23 Jun 2026
Avenue Venture Opportunities Fund II, L.P.
13D/G
5%
$2,877,521
4,641,163 shares
+$2,034,598 23 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$216,779.

Buys
$216,779
Insiders: 2
Sells
$0
Insiders: 0
Net
+$216,779
Shares: +254,872
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 254,872 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 248,972 0 $199,999 $0 +$199,999
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 5,900 0 $16,780 $0 +$16,780

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 25 reporting-owner rows connected to CalciMedica, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
25
Largest Forms 3/4/5 holder
Sanderling Venture Partners VI Co Investment Fund LP
Net 12M change
+$216,779
Latest report
19 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Sanderling Venture Partners VI Co Investment Fund LP 10%+ Owner $9,026,895 Mixed 01 Nov 2024
Sanderling Venture Partners VI LP 10%+ Owner $8,526,033 Filing P/S 23 Jan 2024
ALAFI CAPITAL CO LLC 10%+ Owner $5,265,715 Median 19 Aug 2026
Valence Investments SPV IV LLC 10%+ Owner $2,736,985 Mixed 20 Mar 2023
Fred A. Middleton Director, 10%+ Owner $1,738,404 +$199,999 +13% Mixed 25 Jun 2026
Evgeny Zaytsev Director $1,141,297 Mixed 19 Aug 2026
Robert N. Wilson Director $866,511 Mixed 19 Aug 2026
Eric W. Roberts CHIEF BUSINESS OFFICER, Director $763,605 +$16,780 +2.2% Mixed 19 Aug 2026
A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director $573,198 Mixed 19 Aug 2026
Robert S. Breuil Chief Financial Officer $130,777 Mixed 23 Mar 2023
Parisa Zamiri Chief Medical Officer $107,291 Mixed 23 Mar 2023
Sudarshan Hebbar Chief Medical Officer $100,453 Mixed 19 Aug 2026
Stephen Bardin Chief Financial Officer $73,307 Mixed 05 Apr 2026
Kenneth A. Stauderman Chief Scientific Officer $51,258 Filing P/S 05 Apr 2026
Michael J. Dunn President and COO $16,348 Mixed 05 Apr 2026
Christina Ackermann Director $5,290 Mixed 23 Mar 2023
Dirk Sauer Director $5,290 Mixed 23 Mar 2023
Christy L. Shaffer Director $5,290 Mixed 23 Mar 2023
Julia Marie Eastland Director $5,290 Mixed 23 Mar 2023
Frederic Guerard Director Mixed 19 Aug 2026

Recent insider transactions for CalciMedica, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Alafi Capital Co Llc CALC Series B Warrants Award 3,529,192 3,529,192 19 Aug 2026 Direct
Alafi Capital Co Llc CALC Series A Warrants Award 3,529,192 3,529,192 19 Aug 2026 Direct
Allan Shaw CALC Director Stock Option (Right to Buy) Award 10,000 10,000 19 Aug 2026 Direct
Alan Glicklich CALC Director Stock Option (Right to Buy) Award 10,000 10,000 19 Aug 2026 Direct
Frederic Guerard CALC Director Stock Option (Right to Buy) Award 10,000 10,000 19 Aug 2026 Direct
Evgeny Zaytsev CALC Director Stock Option (Right to Buy) Award 10,000 10,000 19 Aug 2026 Direct
Evgeny Zaytsev CALC Warrant Award 2,900,534 1,450,267 19 Aug 2026 By Bering Partners II, L.P.
Robert N. Wilson CALC Director Stock Option (Right to Buy) Award 10,000 10,000 19 Aug 2026 Direct
Robert N. Wilson CALC Warrant Award 2,365,242 1,182,621 19 Aug 2026 Direct
Sudarshan Hebbar CALC Warrant Award 248,972 124,486 19 Aug 2026 Direct
Eric W. Roberts CALC Warrant Award 373,458 186,729 19 Aug 2026 Direct
A. Rachel Leheny CALC Warrant Award 373,458 186,729 19 Aug 2026 Direct
Evgeny Zaytsev CALC Director Stock Option (Right to Buy) Award 20,000 20,000 02 Jul 2026 Direct
Fred A. Middleton CALC Common Stock Purchase 30.6% $199,999 $0.8033 248,972 1,063,272 25 Jun 2026 By Sanderling Venture Partners VI Co-Investment Fund, L.P.
Sudarshan Hebbar CALC Common Stock Award 202.3% 124,486 186,025 25 Jun 2026 Direct
Robert N. Wilson CALC Common Stock Award 280.2% 1,182,621 1,604,650 25 Jun 2026 Direct
Eric W. Roberts CALC Common Stock Award 103.9% 186,729 366,435 25 Jun 2026 Direct
A. Rachel Leheny CALC Common Stock Award 142.6% 186,729 317,655 25 Jun 2026 Direct
Alan Glicklich CALC Director Stock Option (Right to Buy) Award 937 937 13 Oct 2025 Direct
Eric W. Roberts CALC Common Stock Purchase 3.06% $7,675 $3.07 2,500 84,150 18 Sep 2025 By FMTC Custodian - Roth IRA FBO Eric W. Roberts
Eric W. Roberts CALC Common Stock Purchase 4.35% $9,105 $2.68 3,400 81,650 15 Sep 2025 By FMTC Custodian - Roth IRA FBO Eric W. Roberts
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .